DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
Jung, Hyunchul, Kim, Hong Sook, Kim, Jeong Yeon, Sun, Jong-Mu, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Esteller, Manel, Lee, Se-Hoon, Choi, Jung Kyoon
Published in Nature communications (19.09.2019)
Published in Nature communications (19.09.2019)
Get full text
Journal Article
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
Kim, Nayoung, Kim, Hong Kwan, Lee, Kyungjong, Hong, Yourae, Cho, Jong Ho, Choi, Jung Won, Lee, Jung-Il, Suh, Yeon-Lim, Ku, Bo Mi, Eum, Hye Hyeon, Choi, Soyean, Choi, Yoon-La, Joung, Je-Gun, Park, Woong-Yang, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju, Lee, Hae-Ock
Published in Nature communications (08.05.2020)
Published in Nature communications (08.05.2020)
Get full text
Journal Article
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Sun, Jong-Mu, Shen, Lin, Shah, Manish A, Enzinger, Peter, Adenis, Antoine, Doi, Toshihiko, Kojima, Takashi, Metges, Jean-Philippe, Li, Zhigang, Kim, Sung-Bae, Cho, Byoung Chul, Mansoor, Wasat, Li, Shau-Hsuan, Sunpaweravong, Patrapim, Maqueda, Maria Alsina, Goekkurt, Eray, Hara, Hiroki, Antunes, Luis, Fountzilas, Christos, Tsuji, Akihito, Oliden, Victor Castro, Liu, Qi, Shah, Sukrut, Bhagia, Pooja, Kato, Ken
Published in The Lancet (British edition) (28.08.2021)
Published in The Lancet (British edition) (28.08.2021)
Get full text
Journal Article
MDSC subtypes and CD39 expression on CD8+ T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC
Koh, Jiae, Kim, Youjin, Lee, Kyoung Young, Hur, Joon Young, Kim, Mi Soon, Kim, Boram, Cho, Hee Jin, Lee, Yeong Chan, Bae, Yeon Hee, Ku, Bo Mi, Sun, Jong‐Mu, Lee, Se‐Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung‐Ju
Published in European journal of immunology (01.11.2020)
Published in European journal of immunology (01.11.2020)
Get full text
Journal Article
Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
Eun, Yeonghee, Kim, In Young, Sun, Jong-Mu, Lee, Jeeyun, Cha, Hoon-Suk, Koh, Eun-Mi, Kim, Hyungjin, Lee, Jaejoon
Published in Scientific reports (01.10.2019)
Published in Scientific reports (01.10.2019)
Get full text
Journal Article
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study
Shen, Lin, Kato, Ken, Kim, Sung-Bae, Ajani, Jaffer A, Zhao, Kuaile, He, Zhiyong, Yu, Xinmin, Shu, Yongqian, Luo, Qi, Wang, Jufeng, Chen, Zhendong, Niu, Zuoxing, Zhang, Longzhen, Yi, Tienan, Sun, Jong-Mu, Chen, Jianhua, Yu, Guohua, Lin, Chen-Yuan, Hara, Hiroki, Bi, Qing, Satoh, Taroh, Pazo-Cid, Roberto, Arkenau, Hendrick-Tobias, Borg, Christophe, Lordick, Florian, Li, Liyun, Ding, Ningning, Tao, Aiyang, Shi, Jingwen, Van Cutsem, Eric
Published in Journal of clinical oncology (10.09.2022)
Published in Journal of clinical oncology (10.09.2022)
Get full text
Journal Article
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer
Jung, Hyun Ae, Noh, Jae Myoung, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Pyo, Hongryull, Ahn, Yong Chan, Park, Keunchil
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2020)
Get full text
Journal Article
Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Park, Sehhoon, Oh, Dongryul, Choi, Yoon‐La, Chi, Sang Ah, Kim, Kyunga, Ahn, Myung‐Ju, Sun, Jong‐Mu
Published in Cancer (01.06.2022)
Published in Cancer (01.06.2022)
Get full text
Journal Article
High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program
Park, Sehhoon, Olsen, Steve, Ku, Bo Mi, Lee, Min‐Sang, Jung, Hyun‐Ae, Sun, Jong‐Mu, Lee, Se‐Hoon, Ahn, Jin Seok, Park, Keunchil, Choi, Yoon‐La, Ahn, Myung‐Ju
Published in Cancer (15.08.2021)
Published in Cancer (15.08.2021)
Get full text
Journal Article
Genomic landscape of acquired resistance to third‐generation EGFR tyrosine kinase inhibitors in EGFR T790M‐mutant non–small cell lung cancer
Lee, Jiyun, Kim, Hong Sook, Lee, Boram, Kim, Hee Kyung, Sun, Jong‐Mu, Ahn, Jin Seok, Ahn, Myung‐Ju, Park, Keunchil, Lee, Se‐Hoon
Published in Cancer (01.06.2020)
Published in Cancer (01.06.2020)
Get full text
Journal Article
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer
Kato, Ken, Shah, Manish A, Enzinger, Peter, Bennouna, Jaafar, Shen, Lin, Adenis, Antoine, Sun, Jong-Mu, Cho, Byoung Chul, Özgüro lu, Mustafa, Kojima, Takashi, Kostorov, Vladimir, Hierro, Cinta, Zhu, Ying, McLean, Lee Anne, Shah, Sukrut, Doi, Toshihiko
Published in Future oncology (London, England) (01.04.2019)
Published in Future oncology (London, England) (01.04.2019)
Get full text
Journal Article
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer
Park, Sehhoon, Ock, Chan-Young, Kim, Hyojin, Pereira, Sergio, Park, Seonwook, Ma, Minuk, Choi, Sangjoon, Kim, Seokhwi, Shin, Seunghwan, Aum, Brian Jaehong, Paeng, Kyunghyun, Yoo, Donggeun, Cha, Hongui, Park, Sunyoung, Suh, Koung Jin, Jung, Hyun Ae, Kim, Se Hyun, Kim, Yu Jung, Sun, Jong-Mu, Chung, Jin-Haeng, Ahn, Jin Seok, Ahn, Myung-Ju, Lee, Jong Seok, Park, Keunchil, Song, Sang Yong, Bang, Yung-Jue, Choi, Yoon-La, Mok, Tony S, Lee, Se-Hoon
Published in Journal of clinical oncology (10.06.2022)
Published in Journal of clinical oncology (10.06.2022)
Get full text
Journal Article
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B
Hong, Joohyun, Lee, Jiyun, Park, Sehhoon, Jung, Hyun‐Ae, Sun, Jong‐Mu, Lee, Se‐Hoon, Ahn, Jin Seok, Sinn, Dong Hyun, Ahn, Myung‐Ju
Published in Cancer (01.05.2024)
Published in Cancer (01.05.2024)
Get full text
Journal Article
Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC
Kim, Youjin, Lee, Boram, Shim, Joon Ho, Lee, Se-Hoon, Park, Woong-Yang, Choi, Yoon-La, Sun, Jong-Mu, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil
Published in Journal of thoracic oncology (01.02.2019)
Published in Journal of thoracic oncology (01.02.2019)
Get full text
Journal Article
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease
Shin, Sun Hye, Park, Hye Yun, Im, Yunjoo, Jung, Hyun Ae, Sun, Jong‐Mu, Ahn, Jin Seok, Ahn, Myung‐Ju, Park, Keunchil, Lee, Ho Yun, Lee, Se‐Hoon
Published in International journal of cancer (01.11.2019)
Published in International journal of cancer (01.11.2019)
Get full text
Journal Article
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study
Ahn, Myung-Ju, Han, Ji-Youn, Lee, Ki Hyeong, Kim, Sang-We, Kim, Dong-Wan, Lee, Yun-Gyoo, Cho, Eun Kyung, Kim, Joo-Hang, Lee, Gyeong-Won, Lee, Jong-Seok, Min, Young Joo, Kim, Jin-Soo, Lee, Sung Sook, Kim, Hye Ryun, Hong, Min Hee, Ahn, Jin Seok, Sun, Jong-Mu, Kim, Heung Tae, Lee, Dae Ho, Kim, Sohee, Cho, Byoung Chul
Published in The lancet oncology (01.12.2019)
Published in The lancet oncology (01.12.2019)
Get full text
Journal Article
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer
Ku, Bo Mi, Bae, Yeon Hee, Lee, Kyoung Young, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Published in Investigational new drugs (01.04.2020)
Published in Investigational new drugs (01.04.2020)
Get full text
Journal Article
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer
Ku, Bo Mi, Kim, Youjin, Lee, Kyoung Young, Kim, Sang‐Yeob, Sun, Jong‐Mu, Lee, Se‐Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung‐Ju
Published in European journal of immunology (01.04.2021)
Published in European journal of immunology (01.04.2021)
Get full text
Journal Article
Regulatory (FoxP3 + ) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Koh, Jiae, Hur, Joon Young, Lee, Kyoung Young, Kim, Mi Soon, Heo, Jae Yeong, Ku, Bo Mi, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Published in Scientific reports (04.11.2020)
Published in Scientific reports (04.11.2020)
Get full text
Journal Article
Prognostic and predictive value of KRAS mutations in advanced non-small cell lung cancer
Sun, Jong-Mu, Hwang, Deok Won, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil
Published in PloS one (28.05.2013)
Published in PloS one (28.05.2013)
Get full text
Journal Article